Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Other Working Capital Changes (2016 - 2025)

Bio-Techne (TECH) has 17 years of Other Working Capital Changes data on record, last reported at $1.0 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 137.89% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $14.6 million, up 344.01%, while the annual FY2025 figure was $14.4 million, 356.83% up from the prior year.
  • Other Working Capital Changes reached $1.0 million in Q4 2025 per TECH's latest filing, up from -$380000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $7.2 million in Q2 2025 and bottomed at -$3.4 million in Q1 2022.
  • Average Other Working Capital Changes over 5 years is $1.2 million, with a median of $1.1 million recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: tumbled 325.75% in 2022, then surged 4003.61% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $1.2 million in 2021, then crashed by 325.75% to -$2.6 million in 2022, then rose by 12.54% to -$2.3 million in 2023, then decreased by 18.87% to -$2.8 million in 2024, then skyrocketed by 137.89% to $1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $1.0 million in Q4 2025, -$380000.0 in Q3 2025, and $7.2 million in Q2 2025.